DUBLIN, Calif., Oct. 22 /PRNewswire-FirstCall/ -- SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the 7th Annual Biotechnology Industry Organization (BIO) Investor Forum on Wednesday, October 29, 2008, at the Palace Hotel in San Francisco.
SuperGen's presentation at the BIO Investor Forum is scheduled to begin at 4:15 p.m. PDT (7:15 p.m. EDT). A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. A webcast replay of the presentation will be available shortly following the live event.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
CONTACT: Media, Michael Beckerich of Dorland Global Public Relations,
+1-212-677-7632, mbeckerich@dorland.com, or Timothy L. Enns, SVP, Corporate
Communications & Business Development, +1-925-560-0100, tenns@supergen.com,
or Mary M. Vegh, Manager, Investor Relations, +1-925-560-2845,
mary.vegh@supergen.com, both of SuperGen, Inc.
Web site: http://www.supergen.com/
